[Clinical trial of coenzyme A in hepatopathies]

Coenzyme A (900 L.U. i.v.) was administered for 20 days in 18 cases of viral hepatitis, 2 of chronic ethylic hepatosis, and 5 of ascitic portal cirrhosis. Blood lactic acid, pyruvic acid, serum transaminase and beta/alpha lipoprotein ratio were determined. BSF and colloidal serolability tests were also carried out. The benefits of coenzyme A treatment were particularly indicated by the significant changes noted in lactic and pyruvic acid values.